Skip to Main Content
1-877-YALEMDS
SpecialistsFact SheetsDepartmentsClinical TrialsNewsPatient ToolsFor Medical Professionals
1-877-YALEMDS
  • Search
  • Clinical Trials
  • Uterine Sarcoma

Clinical Trials

    • Cancer(4)
  • Thyroid and Other Endocrine Cancers, Gynecological Cancers

    Endometrium and Metabolism

    • Gynecological Cancers

      A Phase II/III Study of Paclitaxel/Carboplatin Alone or Combined With Either Trastuzumab and Hyaluronidase-oysk (HERCEPTIN HYLECTA) or Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (PHESGO) in HER2 Positive, Stage I-IV Endometrial Serous Carcinoma or Carcinosarcoma

      • Gynecological Cancers

        A Phase 3, Randomized, Open-Label Study of Combination Therapy With Avutometinib Plus Defactinib Versus Investigator's Choice of Treatment in Patients With Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) (RAMP 301)

        • GenderFemale only
      • Gynecological Cancers

        A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of Lademirsen (SAR339375) for Subcutaneous Injection Administered Every Week in Patients With Alport Syndrome

        • About Us
        • Contact Us
        • Donate
        • Referring Doctors
        • Clinical Keywords

        333 Cedar St.

        New Haven, CT 06510

        • Yale School of Medicine
        • Yale University
        • Terms & Privacy Policies
        • Accessibility at YSM
        • Patient Rights
        • HIPAA at Yale
        • Non-discrimination Statement
        Copyright 2025 Yale Medicine